Screening smear for cervical cancer (25-64 years)

Key figures
Data
Graphics
Comments

PROVIDERS & PRESCRIBERS
Main healthcare providers: Gynaecology and midwifery	91.00%
Main prescribers: Not applicable	-
RATE OF USE
Average number of interventions (per year)	443,416
Standardised rate of use (per 100,000 insured persons)	14,773.15
≥ 2 occurences per patient 2018	0.1%
Percentage of outpatient care	99.78%
POPULATION
Median age	43 years
Max/min ratio of the median age (by district)	1.18
Percentage of women	100.00%
Ratio Preferential rate/General rate	0.74
TRENDS
Trend 2010-2019	-2.50%
Trend 2017-2019	1.63%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2010-2012	6.60
Coefficient of variation 2017-2019	9.00
Max/min ratio of number of interventions (per 100,000 insured persons, by region)	1.06
Max/min ratio of number of interventions (per 100,000 insured persons, by district)	2.19
DIRECT EXPENDITURE
Average annual expenditure	16,869,597 €
Average annual expenditure per insured person	5.62 €
Max/min ratio of expenditure per insured person (by region)	1.35
Max/min ratio of expenditure per insured person(by district)	3.04
Average cost of interventions	38.04 €

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - NIHDI nomenclature codes selected for analysis Click to collapse

CODES	LABEL	CREATION	DELETION
114030 114041	Réalisation d'un frottis cervical et vaginal en vue d'un examen cytopathologique, effectué dans le cadre du dépistage de cellules néoplasiques	02-04-1988
149612 149623	Réalisation d'un frottis cervical et vaginal en vue d'un examen cytopathologique, effectué par un médecin spécialiste, dans le cadre du dépistage de cellules néoplasiques	01-08-1988
588873 588884	Honoraires pour l'examen complémentaire de deuxième lecture du frottis examiné en première lecture 589853-589864 pour la recherche lors d'un examen cyto-pathologique de dépistage de cellules néoplasiques sur prélèvement cervico-vaginal, en utilisant la technique de cytologie en phase liquide, quel que soit le nombre de prélèvements	01-07-2009
588932 588943	Honoraires pour la recherche de l'HPV à haut risque au moyen d'une méthode de diagnostic moléculaire sur le même prélèvement cervico-vaginal que la prestation 589853-589864 ou 588873 - 588884	01-07-2009
589853 589864	Honoraires pour la recherche préventive d'un examen cytopathologique de dépistage de cellules néoplasiques sur prélèvement cervico-vaginal, en utilisant la technique de la cytologie en phase liquide, quel que soit le nombre de prélèvements	01-04-2018

The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Below is a graph showing the evolution of the breakdown by volume of nomenclature codes used for the rates:

+ - Population selection Click to collapse

Women between 25 and 64 years old

+ - Analysis period Click to collapse

2019

Nomenclature codes
Age, gender and CV
Patient care settings
Reimbursement rate
Trends
Dot Plot
Distribution map
Occurences

WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Whether it is on the very validity of the analysis or on the interpretation of the data, a tool has been specially designed to enable you to give your opinion and contact us. Please download the tool below (in French)* and use it to send us the information you wish to send us. Then simply send it by email. This information is valuable to us.

Thank you very much for your interest and collaboration !

*The tool is updated regularly, make sure you have the latest version which is the one available here.

CONTACT

Send us an email